Sign in
4

Changes in Ownership

Acrivon Therapeutics, Inc. Filed Acc 0000905148-24-003226

Chief Financial Officer gave up 368 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Holm-Jorgensen Rasmus · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-14 Shares withheld for taxes : show line 1 in the form −368 $7.92 $2,915 26,522 D
Loading xslF345X05/form4.xml…